E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers Tenders > Headlines for 2016 > News item
Published on 12/5/2016 in the Prospect News Liability Management Daily and Prospect News Private Placement Daily.

Ironwood Pharmaceuticals calls Linaclotide PhaRMA 11% notes due 2024

New York, Dec. 5 – Ironwood Pharmaceuticals, Inc. will redeem its 11% Linaclotide PhaRMA notes due 2024 on Jan. 5.

The company will pay par plus accrued interest, according to a notice.

Completion of the redemption is conditional on the closing of the sale of 8 3/8% notes due 2026 that was announced in September.

Ironwood is a Cambridge, Mass.-based pharmaceutical company with treatments for gastrointestinal illnesses.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.